Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.

about

Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.

Item

http://www.wikidata.org/entity/Q38921996

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Moderate hypofractionated radi ...... rradiation in prostate cancer.

@en

type

Item

label

Moderate hypofractionated radi ...... rradiation in prostate cancer.

@en

prefLabel

Moderate hypofractionated radi ...... rradiation in prostate cancer.

@en

P1476

Moderate hypofractionated radi ...... rradiation in prostate cancer.

@en

P2093

A Fogliata

http://www.w3.org/2001/XMLSchema#string

G R D'Agostino

http://www.w3.org/2001/XMLSchema#string

L Cozzi

http://www.w3.org/2001/XMLSchema#string

L Di Brina

http://www.w3.org/2001/XMLSchema#string

P Navarria

http://www.w3.org/2001/XMLSchema#string

P2860

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas

Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes.

Relationship between two year PSA nadir and biochemical recurrence in prostate cancer patients treated with iodine-125 brachytherap.

Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.

Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement

P2888

s00432-017-2375-9

P304

1301-1309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-017-2375-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Marta Scorsetti

Tiziana Comito

Ciro Franzese

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28271215

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy